Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01822717 · ClinicalTrials.gov registry record · NA

Nonvisual Foot Inspection for People With Visual Impairment

A NA study of Diabetes and Visual Impairment, sponsored by Case Western Reserve University.

Completed
Registry status
NA
Development phase
30
Enrollment target
1
Study location

NCT01822717: Completed NA study of Diabetes and Visual Impairment, sponsored by Case Western Reserve University.

NCT01822717 is a NA study of Diabetes and Visual Impairment that has completed, run by Case Western Reserve University. The registered enrollment target is 30 participants, below the 3,028-participant average among 338 other Diabetes trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01822717, a NA study of Diabetes and Visual Impairment, has completed, sponsored by Case Western Reserve University.

COMPLETED
Registry status
NA
Development phase
30 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study was to find out whether a method of nonvisual foot inspection, using the senses of touch and smell, helps people with diabetes and visual impairment to find new foot problems when they are in early, easily-treated stages. All people in the study had regular foot inspections by podiatrists. The results include how people feel about the method, whether they actually did check their feet it, and whether the method helped them to discover foot problems themselves.

Primary Outcome

Number of days in the last week each participants reported checking their feet for problems, using nonvisual methods (experimental group) or with assistance form someone else (comparison group)

Interventions

  • BEHAVIORAL Usual Care
  • BEHAVIORAL Nonvisual foot inspection

Study Locations (1)

Ohio

  • Cleveland Foot and Ankle Institute - Cleveland

Trial Details

FieldValue
Enrollment Target 30 participants
Start Date 2010-09
Est. Completion 2012-09
Phase NA
Case Western Reserve University

141 total trials

What the finished NCT01822717 record still lists

NCT01822717 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 3,028-participant average among 338 other Diabetes trials with a reported enrollment target (99% lower).

The record links to 2 conditions, with Diabetes appearing as the primary indexed condition, and to 2 interventions - of which Usual Care is the first listed.

NCT01822717 reports a single indexed study location in Ohio.

Frequently Asked Questions

What is clinical trial NCT01822717 about?

NCT01822717 is a clinical study titled "Nonvisual Foot Inspection for People With Visual Impairment". The purpose of this study was to find out whether a method of nonvisual foot inspection, using the senses of touch and smell, helps people with diabetes and visual impairment to find new foot problems when they are in early, easily-treated stages. All people in the study had regular foot inspections...

What is the current status of trial NCT01822717?

This trial is currently completed. It is a NA study. The enrollment target is 30 participants. The study started on 2010-09. Estimated completion is 2012-09.

What conditions does trial NCT01822717 study?

This clinical trial studies the following conditions: Diabetes, Visual Impairment.

What interventions are being tested in trial NCT01822717?

The interventions under investigation include: Usual Care (BEHAVIORAL), Nonvisual foot inspection (BEHAVIORAL).

Who is sponsoring clinical trial NCT01822717?

This trial is sponsored by Case Western Reserve University, which has 141 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01822717 being conducted?

This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Diabetes

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT01822717's enrollment target sits among peer trials

30 281st of 338 higher than 51 of 338 other Diabetes trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Diabetes trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00977977 · 30 participants · Phase 2

    Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy

  • NCT01459107 · 30 participants · Phase 2

    Human Upper Extremity Allotransplantation

  • NCT01666080 · 30 participants · NA

    Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)

  • NCT01720836 · 30 participants · Phase 1

    Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01822717, the US trial registry maintained by the National Library of Medicine. NCT01822717 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.